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Abstract
Chloride is the principal anion of the extracellular fluid and vital for both serum
electroneutrality and acid-base homeostasis. The aim of this review is to investigate
the relevance of dyschloremia in the critically ill.
An extensive literature research was conducted on www.pubmed.org. In addition,
the references of included articles were searched for further possible investigation
regarding chloride.
Articles investigating the relevance of dyschloremia in the critically ill were included.
All articles were screened in regard to dyschloremia in the critically ill.
Chloride is essential for blood pressure control, decarboxylation/gas transport, renal
function, and gastrointestinal homeostasis. “Dyschloremia,” i.e., serum chloride levels
not within the limits of normal, may commonly be observed on ICUs and appear
mainly induced by iatrogenic measures (i.e., infusion of chloride-rich fluids). Hypo-
and hyperchloremia appear linked to increased mortality in defined ICU populations,
but evidence is sparse. Data show that hyperchloremia may not only be linked to
hyperchloremic metabolic acidosis, but also to increased hemodynamic instability
and vasopressor need (e.g., in patients after major surgery). Nevertheless, it is
currently unknown whether such effects would be directly or indirectly mediated.
Moreover, recent evidence points to an increased incidence of acute kidney injury
and need for renal replacement therapy in patients with advanced hyperchloremia.
Current knowledge on chloride is largely limited by heterogeneous trial design and
mostly abundant data on specific fluid replacement strategies. The aim of this review
is to summarize key consequences of chloride in critical illness and to discuss
implications for daily clinical practice and future research.
Keywords: Renal function, Intensive care, Electrolytes, Mortality, Acid-base disorder
Review
The chloride ion (Cl−, molar mass 35.45 g/mol) is the principal extracellular anion in
humans [1–3]. Intra- and extracellular chloride concentrations range from 2 to 5 mmol/L
(skeletal muscles) to about 90 mmol/L (erythrocytes), and 97–107 mmol/L (plasma).
Chloride is vital for maintenance of serum electroneutrality, acid-base balance, fluid
homeostasis, osmotic pressure, hydrochloric acid (HCl) production in the gastrointestinal
tract, renal function, and for electrical activity in general, e.g., in muscular activity [1, 2].
Hyperchloremia has a high prevalence in critically ill patients with data showing that
it may be observed in about 25–45% of ICU patients; however, this seems not acknowl-
edged by previous research or textbooks. Data from a recent prospective observational
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investigation demonstrate that temporary hyperchloremia may even occur in 75% of
ICU patients during the first 24 h of ICU stay [4]. However, despite a rather high preva-
lence in critically ill patients, few outcome-related data regarding systemic chloride
levels exist. The available data indicate that in general, increased disease severity is as-
sociated with abnormal chloride levels (reviewed in [1]). This review aims to provide an
overview on chloride physiology and to reflect outcome-relevant effects of chloride in
critically ill patients.
Physiological functions of chloride—a quick overview
In humans, dietary salt intake is the primary Cl− source (about 6–12 g, respectively
100–200 mmol Cl−) [1, 5]. Cl− is vital for several key physiological functions discussed
below (Fig. 1).
Acid-base equilibrium
Cl− is the major extracellular strong ion and is key to maintenance of acid-base homeo-
stasis [1, 6, 7]. Cl− levels are inversely related to bicarbonate [1], which acts as the
major acid-base buffer in humans [1]. Cl− was identified as the primary factor
influencing the occurrence of metabolic alkalosis and non-anion gap metabolic acidosis
in critical illness [6].
The influence of Cl− acid base homeostasis can be explained by the “Stewart
approach” (Fig. 2), where the potential proton concentration of a given solute is
determined by changes in any of three independent variables: (1) difference in so-called
Fig. 1 The principal physiological functions of chloride in the human body
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strong ions (SID) where Cl− plays a major role, (2) carbon dioxide partial pressure,
and (3) non-volatile weak acid concentration [7, 8]. In addition, Cl− levels are
significantly influenced by compensatory factors, urine electrolyte, and bicarbonate
concentrations and water homeostasis. The influence of Cl− on acid-base homeo-
stasis is provided in Fig. 3.
Influence of chloride on renal function and blood pressure
Cl− undergoes free glomerular filtration with 99% being reabsorbed and about
180 mmol of Cl− excreted per day [1, 9]. Cl− reabsorption occurs in the proximal renal
tubule (~ 60%) and partly in intercalated cells of the distal nephron. In the ascending part
of Henle’s loop, another 25% of Cl− is reabsorbed [1, 9–11]. In euvolemia, Cl− levels
Fig. 2 Acid-base physiology according to the Stewart’s approach
Fig. 3 Influence of chloride on acid-base homeostasis
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regulate active sodium-potassium and Cl− reabsorption [1] by tubular-glomerular feed-
back with Cl− sensing in the macula densa. This feedback may induce renal afferent
vasoconstriction and reduced glomerular filtration [11–14]. Moreover, Cl− levels affect
renin secretion and Cl− concentrations at the macula densa and are inversely related to
renin-angiotensin-aldosterone system (RAAS) activation [1, 12]. Several preclinical studies
showed that Cl− depletion induced stimulation of renin secretion resulting in increased
systemic blood pressure [15]. In addition, Cl− concentrations may exert direct effects on
smooth muscle cells resulting in vasoconstriction [5].
Gastrointestinal function of chloride
Cl− has two distinct functions in the gastrointestinal (GI) tract: first, it is secreted in
form of HCL and is required for protein digestion, microorganism homeostasis, and
absorption of nutrients (e.g., calcium, zinc, iron, vitamins, folic acid) [1]. Second, it is
responsible for maintenance of the GI osmotic gradient and fluid secretion [1]. The
role of Cl− in splanchnic perfusion is discussed controversially with few animal data
indicating that increased Cl− levels lead to impaired gastric-pyloric motility, nausea,
and vomiting [16].
Effects of chloride on oxygen transport and gas exchange
Intracellular Cl− are lower than extracellular Cl− levels [1]. The extracellular vs.
intracellular Cl− distribution mainly depends on cell membrane potentials that are
established by transmembrane electrolyte transport [1]. Erythrocytes have low
membrane potentials allowing for almost free transmembrane Cl− passage [1] and
anion exchange mainly occurs via an Cl−/HCO3
− antiport. The underlying physiological
mechanism (Cl−/HCO3
−exchange) is referred to as “Hamburger shift” and seems key to
understanding carbon dioxide (CO2) transport. In fact, when blood passes through the
venous system with high CO2 pressures, a chloride efflux and concurrent bicarbonate
influx (derived from CO2; CO2 uptake) occurs which is diffused while respective blood
is arterialized in the pulmonary system [17, 18]. This Cl− shift plays a role in oxygen
(O2) unloading also [17, 18]. Nevertheless, the clinical significance of this effect needs
confirmation in subsequent investigations.
Clinical conditions associated with “dyschloremia” on the ICU
Definition of “dyschloremia”
Hypochoremia is usually defined as serum chloride levels below 96–101 mmol/l, while
hyperchloremia normally is defined as serum chloride levels higher than 106–111 mmol/l
[19–21]. The definition varies depending on the local laboratory. Chloride levels do
closely interact with the body’s water contact and are highly susceptible to either plasma
contraction or dilution (also see below).
Hypochloremia
Hypochloremia in critically ill patients can be caused by active Cl− loss, e.g., through the
GI tract (e.g., vomiting, diarrhea), via inadequate renal Cl− reabsorption or via dilution
following infusion of hypotonic fluids [1, 9]. Additionally, Cl− can be lost via the kidneys
in cases of increased bicarbonate reabsorption in either chronic respiratory acidosis or
hyper-aldosteronism. High-volume bicarbonate infusion may result in Cl− being
exchanged for bicarbonate in order to maintain electroneutrality [1]. Key to
understanding of hypochloremia thus is assessment of potential iatrogenic effects and/or
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related use of diuretics [3]. Especially, the use of furosemide is clearly associated with the
occurrence of metabolic alkalosis [22]. Plasma contraction further aggravates
hypochloremic metabolic alkalosis especially in patients who lose high quantities of
chloride-rich fluids (e.g., vomiting) [23].
Hyperchloremia
Hyperchloremia in critically ill patients is mainly due to (1) loss of bicarbonate through
the GI or renal tract, (2) as a consequence of “dilution” due to volume loading with
fluids with a low bicarbonate concentration, or (3) by excess infusion of Cl−-rich fluids
[1]. On the ICU, diarrhea may be the most often reason for bicarbonate loss [1].
Bicarbonate may also be lost through the renal system in renal tubular acidosis (RTA),
especially in proximal RTA type II [1, 24].
Further, plasma “dilution” may also decrease bicarbonate levels [25, 26]. This typically
results in increased Cl− levels and “dilutional acidosis”—which was also observed after
infusion of large quantities of chloride-rich fluids [12, 25, 26].
Hyperchloremia in critical illness most often results from iatrogenic chloride overload
(e.g., 0.9% NaCl infusion with 154 mmol/l CL−) [1, 12, 27–30]. Normal saline has a
theoretical SID of zero [1] and thus results in development of hyperchloremic
metabolic acidosis [1, 12]. Despite growing evidence, 0.9% NaCl is still one of the most
widely used crystalloids [12, 30–36]; however, its use is widely debated [37–43].
Importantly, the ICU physician should note that albumin-based replacement fluids may
contain rather large quantities of chloride also [44, 45]. Furthermore cases of hyper-
chloremia on the ICU may result from infusion of HCl, acetazolamide, and/or triamter-
ene therapy, or specific cortisone derivates resulting in NaCl retention [1].
Impact on clinical outcomes of critically ill patients
Hyperchloremic metabolic acidosis
Hyperchloremic metabolic acidosis results from infusion of considerable quantities of
chloride-rich fluids in critically ill patients [27–30, 33, 35, 36, 46–48]. It’s development
is dose-dependent and independent of infusion speed [13]. Importantly, hyperchloremic
metabolic acidosis may not only affect ICU patients with acute kidney injury (AKI)
[28], data also show that a total volume of 2000 ml of chloride-rich infusate may induce
hyperchloremic metabolic acidosis in healthy volunteers [13]. Hyperchloremic meta-
bolic acidosis may induce vasodilatation [49–51], altered neurotransmitter function [52,
53], decreased cardiac reactivity [52, 53], and other changes in cellular function [54], as
well as decreased endogenous catecholamine release [55].
Current literature clearly indicates that chloride-rich infusates are associated with the
temporary occurrence of hyperchloremic metabolic acidosis. However, the significance
of the latter and its influence on clinical endpoints such as the occurrence of kidney
failure or mortality is not jet clarified.
Renal function
Effects of hyperchloremia on renal function were first investigated over 30 years ago
[11, 14]. There is some animal [11, 14, 47] and human data (13) that suggest that renal
blood flow and renal cortical perfusion is diminished under chloride infusion. However,
a recently published trial [56] does not confirm these findings.
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Clinical studies, like animal experiments, showed mixed results regarding
patient-centered clinical outcomes (e.g., need for renal replacement therapy
(RRT)) in ICU patients [4, 33, 35, 37, 46, 57–62] (see, Table 1). Whereas some
clinical trials did not identify changes in serum creatinine or acute kidney injury
(AKI) rates in mixed ICU cohorts, cardiac surgery, or sepsis [37, 59, 62], other
reports demonstrate increased AKI incidence and need for renal replacement
therapy (RRT) [4, 46, 57]. However, the sensitivity analysis of one of these trials
showed that the incidence of AKI and need for renal replacement therapy were
also influenced by other unidentified confounders [57], so the issue is far from
being concluded. This is also confirmed by another recently published retrospect-
ive analysis comparing hypertonic (3%) to normal saline in patients undergoing
emergent laparotomy that showed no difference in respect to renal outcomes be-
tween the groups, even though the chloride levels were significantly higher in the
hypertonic saline group [63].
In addition, unfortunately, methodology, terminology, amount of total volume ap-
plied, and triggers for RRT differed considerably between trials. Overall, it appears that
trials with lower total amount of Cl− infusion (i.e., 1–2 L/24 h) found unaffected AKI
rates [37, 59], whereas trials with higher infusion rates showed an increased AKI
incidence and RRT need [4, 35, 46, 57] suggesting a dose-dependent effect. Despite the
enormous heterogeneity in the available literature which makes it almost incomparable,
a recently published meta-analysis [33] included randomized and non-randomized trials
concluded that use of chloride-rich fluids is associated with a higher AKI risk.
Interestingly, increased serum Cl− levels alone, independent of i.v. fluid, were
associated with a higher AKI risk in several studies [4, 64, 65]. As to chloride levels,
studies show that only minimal and/or maximum Cl− levels during ICU stay [61] but
not ICU admission levels [64] were associated with an increased AKI incidence. An
increase of Cl− serum levels by 10 mmol/l resulted in OR 7.39 for AKI development in
one study [65]. However, the number of study focusing on chloride levels independent
of i.v. fluids is still a few.
In conclusion, despite the number of studies focusing on the development of AKI
and need for RRT in patients receiving chloride-rich infusates, the debate is far from
being decided due to the large heterogeneity in the available literature.
Cardiovascular function
Chloride-rich infusions may lead to hemodynamic instability [27, 28, 31, 47].
Hemodynamic effects of chloride-rich fluids were first described by Kellum and co-
workers in a rodent sepsis model [47]. In this model, hyperchloremia and associated
metabolic acidosis induced decreased arterial pressures [47]. This effect was confirmed
in additional studies showing decreased mean arterial blood pressures and cardiac
index in rats with abdominal sepsis [31]. In critically ill humans, patients receiving
chloride-rich infusions had a volume-dependent increased vasopressor need [27]. A
randomized controlled double-blind study by members of our group focusing on nor-
mal saline when compared to an acetate-buffered infusion solution in patients undergo-
ing major abdominal surgery even shows, that the effect is not only volume-dependent,
but also time-dependent [66]. The mechanisms behind this effect remain somewhat
elusive. Further trials comparing other infusion solutes in respect to cardiovascular sta-
bility are certainly needed before drawing definitive conclusions.
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Hypochloremia seems of particular importance in heart failure patients where low
levels of serum chloride indicate advanced disease, and are associated with decreased
left ventricular ejection fraction [38, 67–69], increased cardiac function markers (e.g.,
NT-pro-BNP) [38, 68], and circulating catecholamine levels [70]. In fact, hypochloremia
was identified as an independent predictor for adverse outcome in heart failure patients
and was recently recognized to predict mortality in affected patients [3].
The influence of chloride on the cardiovascular system may be important for clini-
cians for several reasons: first, chloride loading may contribute to catecholamine need
in critically ill patients. Second, cardiac function may be influenced by chloride levels
in a “U-shaped” response curve with both hypo- and hyperchloremia being detrimental
for cardiovascular stability (and function). Third, the effect of chloride-“loading” on
hemodynamic stability may be dose-dependent. Fourth, in preclinical models, it was
shown that simple hyperchloremia may trigger increased blood pressures. However,
only concomitant hyperchloremia with metabolic acidosis results in decreased systemic
pressures [47]. It thus seems likely that the occurrence of acidosis and not hyperchlore-
mia per se is responsible for observed adverse cardiovascular effects.
Inflammation and coagulation
In several animal models, systemic levels of inflammatory makers were increased fol-
lowing chloride-rich infusions. This was observed in both experimental sepsis [12, 39,
47, 71] and trauma models [40]. In humans, this remains controversially discussed [41,
42] as effects of chloride-rich infusions on inflammatory markers may also be attrib-
uted to sodium rather than to Cl−. However, this requires further clarification.
Preclinically, chloride-rich infusions were associated with an increased need for blood
products [35, 40, 43]. Moreover, few evidence points to the fact that hyperchloremia
may influence plasmatic coagulation cascades [40, 43, 72] and/or platelet function [12].
In humans, several trials and a recent meta-analysis demonstrate increased need for
blood product administration in patients receiving chloride-rich infusions [33, 35, 73].
Nevertheless, the effect of acidosis in this context remains uncertain.
Mortality and other patient-centered clinical outcomes
A U-shaped mortality curve was reported in respect to Cl− levels and mortality [12].
This is depicted in Fig. 4. Several large-scale clinical trials in critically ill patients found
increased mortality rates in patients treated with chloride-rich infusions [2, 29, 33, 35,
46, 48, 58, 74, 75]. However, this effect was not confirmed in four other large-scale
multi-center trials and a recent meta-analysis [4, 33, 37, 46, 76]. Even when a very high
Cl− load fluid (hypertonic saline, 3%) was compared to normal Cl− load fluid (0.9%
saline), there was no difference in respect to mortality between these groups [76].
Hyperchloremia itself (at 72 h after ICU admission) or rise in Cl− levels of > 5 mEq/l
was associated with increased in-hospital mortality [2]. Interestingly, two large studies
in SIRS patients [29, 48] found that mortality remained lowest in patients with only
minimal serum Cl− variation during total hospital stay [29]. In-hospital mortality grad-
ually increased with each 10 mmol/l of serum Cl− level increase [29]. This association
was independent of total fluid volume administered, but linked to volume-adjusted
chloride-load [29]. Another study in critically ill patients investigating the prognostic
potency of acid-base variables to reflect in-hospital mortality identified hyperchloremia
and hypoalbuminemia as the only independent factors after adjustment [77].
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In conclusion, even though literature points towards increased mortality rates in pa-
tients with hyperchloremia, it remains unclear whether potential effects of Cl− levels on
mortality are due to direct or indirect (e.g., acidosis) effects.
Hypochloremia was also linked to mortality in several studies [38, 67, 68, 70, 75, 78]
and may be of special importance in patients with heart failure. An inverse relationship
of Cl− levels with mortality in patients with compensated and non-compensated heart
failure was shown [3, 38, 67]. Some studies showed an independent effect of hypochlor-
emia (< 100 mmol/l) on cardiovascular, non-cardiovascular, and all-cause mortality [38,
67, 79]. All-cause mortality rates were increased even after 5 years of follow-up follow-
ing initial hypochloremia [67]. Moreover, a recent editorial concludes that reduced
serum Cl− levels may be of higher prognostic importance than increased sodium levels
in heart failure patients [3].
Unlike with hyperchloremia, hypochloremia is more closely associated with increased
mortality and should certainly be considered by intensive care physicians.
Effects of chloride levels on several other patient-centered relevant clinical out-
comes were investigated. Hyperchloremia was associated with increased length of
mechanical ventilation [33], increased rates of post-operative infectious complica-
tions [35, 48], increased readmission rates [48], and increased ICU and hospital
length of stay [48, 58, 78]. However, these outcomes need to be further evaluated
before drawing any definitive conclusions.
Conclusions
Hypo- or hyperchloremia may often be observed on ICUs, but data on relevant patient-
centered clinical outcomes remain sparse. In fact, most studies investigating “dyschlore-
mia” were heterogeneous and hyperchloremia was a result of infusion of normal saline
(and thus concomitant sodium infusion). Moreover, different laboratory methods to
measure Cl−, definitions of hypo- and/or hyperchloremia, different trial design/
Fig. 4 Influence of chloride levels on mortality. *All tables and figures are propriety of the authors and have
not been published elsewhere
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methodology, and cohorts under investigation add to a considerable heterogeneity of
the available data.
“Dyschloremia,” however, may have a major impact on clinical outcomes in crit-
ical illness. Despite growing evidence favoring avoidance of chloride-rich infu-
sions, e.g., 0.9% NaCl is still one of the most widely used crystalloid and some
authors argue that despite development of hyperchloremic metabolic acidosis, its
clinical significance remains elusive. In respect to renal function, the influence of
hyperchloremia on renal function remains somewhat controversial and the avail-
able literature very heterogenic and almost incomparable. Therefore, no final con-
clusions on the topic of AKI incidence and need for RRT in respect to i.v. fluids
with elevated chloride-content can be drawn. For cardiovascular aspects, growing
evidence indicates that hyperchloremia-associated metabolic acidosis may induce
hemodynamic instability. Hyperchloremia also may also have negative effects on
coagulation cascades and increased mortality.
Interestingly, hypochloremia was much less studied than hyperchloremia although
emerging evidence shows that low chloride levels may largely affect outcome, especially
mortality in patients with heart failure.
In conclusion, “dyschloremia” significantly influences several important outcomes in
the critically ill. However, much of the discussion is subject to an ongoing debate.
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